CN1082821C - 抗体共轭物 - Google Patents

抗体共轭物 Download PDF

Info

Publication number
CN1082821C
CN1082821C CN91105586A CN91105586A CN1082821C CN 1082821 C CN1082821 C CN 1082821C CN 91105586 A CN91105586 A CN 91105586A CN 91105586 A CN91105586 A CN 91105586A CN 1082821 C CN1082821 C CN 1082821C
Authority
CN
China
Prior art keywords
cells
antibody
sea
conjugate
superantigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN91105586A
Other languages
English (en)
Chinese (zh)
Other versions
CN1059278A (zh
Inventor
T·卡兰
G·赫德隆
M·多尔斯滕
E·阿克布卢姆
P·A·兰多
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Active Biotech AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of CN1059278A publication Critical patent/CN1059278A/zh
Application granted granted Critical
Publication of CN1082821C publication Critical patent/CN1082821C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN91105586A 1990-07-20 1991-07-19 抗体共轭物 Expired - Lifetime CN1082821C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002479A SE9002479D0 (sv) 1990-07-20 1990-07-20 Antibody conjugates
SE9002479 1990-07-20

Publications (2)

Publication Number Publication Date
CN1059278A CN1059278A (zh) 1992-03-11
CN1082821C true CN1082821C (zh) 2002-04-17

Family

ID=20380032

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91105586A Expired - Lifetime CN1082821C (zh) 1990-07-20 1991-07-19 抗体共轭物

Country Status (10)

Country Link
CN (1) CN1082821C (https=)
HU (1) HU211917A9 (https=)
IE (1) IE75719B1 (https=)
IL (1) IL98777A (https=)
IS (1) IS3732A7 (https=)
NZ (1) NZ238953A (https=)
PT (1) PT98396B (https=)
SE (1) SE9002479D0 (https=)
TW (1) TW213415B (https=)
ZA (1) ZA915646B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3656769T3 (da) 2017-07-19 2023-02-13 Chia Tai Tianqing Pharmaceutical Group Co Ltd Aryl-phosphor-oxygen-forbindelse som egfr-kinase-inhibitor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306943A2 (en) * 1987-09-10 1989-03-15 Neorx Corporation Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306943A2 (en) * 1987-09-10 1989-03-15 Neorx Corporation Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity

Also Published As

Publication number Publication date
IS3732A7 (is) 1992-01-21
IL98777A0 (en) 1992-07-15
IE912555A1 (en) 1992-01-29
ZA915646B (en) 1992-05-27
NZ238953A (en) 1993-10-26
SE9002479D0 (sv) 1990-07-20
PT98396A (pt) 1992-06-30
PT98396B (pt) 1999-01-29
TW213415B (https=) 1993-09-21
IL98777A (en) 2004-06-20
CN1059278A (zh) 1992-03-11
HU211917A9 (en) 1996-01-29
IE75719B1 (en) 1997-09-24

Similar Documents

Publication Publication Date Title
EP0610179B1 (en) Target specific antibody-superantigen conjugates and their preparation
US6197299B1 (en) Antibody conjugates
US12589101B2 (en) Cyclodextrin protein drug conjugates
CA2793087C (en) Peptides, conjugates and method for increasing immunogenicity of a vaccine
US5858363A (en) Target specific antibody-superantigen conjugates and their preparation
JP2021054845A (ja) グルココルチコイド受容体作動薬及びそのイムノコンジュゲート
CN1464790A (zh) T细胞受体融合物及共轭物以及其使用方法
JP7608360B2 (ja) 徐放性サイトカインコンジュゲート
TW201722483A (zh) 新穎結合劑-藥物接合物（ＡＤＣｓ）及其用途（二）
CN1089606C (zh) 一种修饰的超抗原和一种寻找靶物化合物的缀合物和该缀合物的用途
US20240350657A1 (en) Sulfomaleimide-based linkers and corresponding conjugates
CN117355341A (zh) 用于治疗癌症和/或感染性疾病的tlr7和tlr8激动剂
JPH05238952A (ja) 抗体を伴う薬物のクラスター複合体
CN1082821C (zh) 抗体共轭物
CN1045621C (zh) 免疫球蛋白结合物的制备方法
JP2022523009A (ja) 脱免疫化志賀毒素ａサブユニットエフェクターを含むｃｄ３８結合性タンパク質
JPH05306299A (ja) ナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白質とｈｉｖ−１関連ペプチドとの連結複合体、およびそれを含むワクチン
HK1007955B (en) Target specific antibody-superantigen conjugates and their preparation
US11020490B2 (en) Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit
US20170239346A1 (en) Novel cocaine haptens and nanofiber-based cocaine vaccines
Class et al. Patent application title: NOVEL COCAINE HAPTENS AND NANOFIBER-BASED COCAINE VACCINES
LT3909B (lt) Nauji antikūnio-superantigeno konjugatai, jų gavimo būdas, ląstelės-taikinio ūžavimo būdas ir konjugatų panaudojimas farmacinėse kompozicijose
CN120285216A (zh) 澳瑞他汀类药物的配体-药物偶联物及其制备和应用
HUT71776A (en) Antibody conjugates with improved properties
HK1030882A (en) Immunogenic conjugates comprising a group b meningococcal porin and h. influenzae polysaccharide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Applicant after: Pharmacia AB

Applicant before: Kabi Pharmacia AB

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: KABI PHARMACIA AB TO: FAMERSIA PHARMACY CORP.

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HUOYUE BIOISYSTECH CO., LTD.

Free format text: FORMER OWNER: FAMERSIA PHARMACY CORP.

Effective date: 20040302

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20040302

Address after: Longde, Sweden

Patentee after: Active Biotech AB

Address before: Sweden Sara Appleton

Patentee before: Pharmacia AB

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20110719

Granted publication date: 20020417